EP Patent

EP1435943B1 — Use of 2-oxo-1-pyrrolidine derivatives for the preparation of a drug for treating dyskinesia

Assigned to UCB SA · Expires 2007-02-14 · 19y expired

What this patent protects

The present invention relates to pharmaceutical compositions containing 2-oxo-1-pyrrolidine derivatives and methods for treating Parkinson's Disease in a chronic dopamine replacement therapy using L-DOPA by administering the derivatives.

USPTO Abstract

The present invention relates to pharmaceutical compositions containing 2-oxo-1-pyrrolidine derivatives and methods for treating Parkinson's Disease in a chronic dopamine replacement therapy using L-DOPA by administering the derivatives.

Drugs covered by this patent

Patent Metadata

Patent number
EP1435943B1
Jurisdiction
EP
Classification
—
Expires
2007-02-14
Drug substance claim
No
Drug product claim
No
Assignee
UCB SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.